Cancer researchers focused on improving the success of cancer immunotherapies introduced a new tool in a Yale study published ...
Bioengineers at the University of California San Diego have developed a powerful new technology that can map the entire ...
Researchers at Integra Therapeutics, in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life ...
This photo shows results of a competition assay between yeast cells expressing a fiber with one fluorescent protein, and yeast cells expressing a fiber with a second fluorescent protein. This is an ...
The model aims to help manufacturers assess the likelihood of protein-based drugs being successfully expressed by CHO cells at scale.
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. The bioenergetic requirements of muscle stem ...
High IL1RAP protein expression on tumor cells is linked to poor survival in PDAC patients treated with chemotherapy, while this patient group has the longest survival when treated with nadunolimab in ...
Profacgen Unveils Innovative Animal-Free Protein Expression Systems for Advanced Scientific Research
Profacgen is well-regarded for its custom protein production and bioinformatics solutions that help researchers and industries push the boundaries of science with advanced tools. They’ve come out with ...
Aspiring participants of the GATE 2026 Biotechnology (BT) exam must go through the GATE Biotechnology Syllabus. The detailed ...
Recombinant protein expression is a cornerstone of modern biotechnology, fueling advances in drug development, molecular ...
Editas Medicine Inc. (NASDAQ:EDIT) is one of the best performing penny stocks to buy now. On September 5, HC Wainwright reiterated a “Buy” rating on the stock and a $5 price target. The positive ...
Loopworm recently announced a Series A funding round to commercialize its proprietary recombinant protein platform, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results